Shattuck Labs, Inc.

Shattuck Labs is a biotechnology company that develops antibody drugs to treat inflammatory and immune-system diseases. Antibodies are proteins that help the body fight disease. The company is testing SL-325 and SL-425, experimental antibodies designed to block a protein called death receptor 3, for conditions like inflammatory bowel disease. It is also working on other experimental antibodies and cancer treatments that are still in early development stages. The company was founded in 2016 and is based in Austin, Texas.